However, CRC cells lacking PRDX1 still have considerable basal levels of neddylated CUL5 protein, implying that PRDX1 probably acts as an “enhancer” rather than a “switch” of CRL5 activity. The gene discussed is CUL5; the disease is colorectal carcinoma.